TLV •
Healthcare •
Biotechnology •
Quote as of 07/29/2026 17:24
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTLV
Market Capitalization33.66 mln
Float5.68 mln
Piotroski F-Score
2
/ 9
Weak
Relative Strength
59
/ 100
Slightly ahead
Debt / Equity
0.02
Debt-free
ROE
-42.98
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
BioLight Life Sciences is an Israeli medical company focused on developing and commercializing products for eye care, including tools for diagnosing and treating conditions such as dry eye syndrome and glaucoma. Its portfolio includes diagnostic platforms that analyze tear fluid, implant-based glaucoma treatments, and drug delivery technology that uses nanostructures to improve how active ingredients reach their targets. Founded in 2005 and headquartered in Ramat Gan, the company operates across medical devices, pharmaceuticals, and digital medicine.
